Independent oncology networks the National Cancer Care Alliance (NCCA) and Quality Cancer Care Alliance (QCCA) have launched a new venture, Exigent Research, which comprises 25 independent practices to enhance cancer care. 

The introduction of this venture builds on the QCCA Research Network.

Exigent has been designed to offer centralised services that speed up access to clinical trials for patients by supporting these oncology practices which offer care for over 1.8 million people.

Furthermore, Exigent will be able to offer trials to member practices more rapidly than they can through conventional networks by centralising services such as contracting, budgeting and central IRB.

Leaving unique technology at its top potential, the venture boosts the expertise of each member practice by aiding them in detecting eligible national, regional and local trials.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

See Also:

In addition, this approach will help in including patients in the trials efficiently compared to what an individual practice member would require for supporting such a process. 

Exigent plans to continue the development of its expertise by collaborating with industry and offering access to a wider network of independent practices that aim to offer clinical research at the point of care in their communities.

Through the company, NCCA will be able to back first-in-human, Phase I-IV, pragmatic and accelerated trials on demand (ATOD) that benefit patients directly.

Exigent Research president and CEO Sibel Blau said: “We’ve been working hard to develop a proprietary centralised data warehouse supported by advanced technology that allows us to utilize real-time data coming from our practices every day so that we can better support the patients that need our care faster, smarter, and much more optimally than ever before. 

“As a result, times for enrolment into clinical trials are drastically reduced, creating a lifesaving advantage and democratizing clinical research for all patients regardless of where they live.”